Abstract
AFTER oral administration of radioactive iodine, the uptake of the tracer by the thyroid gland is abnormally high in most cases of untreated hyperthyroidism (1, 2, 3). However, a significant overlap exists between the normal range of uptake and the range in hyperthyroidism (4, 5); cases with uptakes in the range of overlap must be considered borderline. Since it is in these borderline cases that the clinician has most difficulty in establishing the correct diagnosis, any safe procedure which would reduce the area of overlap would be welcome. It seemed desirable to determine if this purpose might be accomplished by administering the tracer intravenously, thereby eliminating the variables of rate and amount of gastrointestinal absorption. It was also hoped that the intravenous method would offer the additional advantages of rapidity and convenience.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
